Dose Escalation For INtraprostatic LEsions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dose Escalation For INtraprostatic LEsions — Stella

Recruiting

Back to Prostatic Neoplasms trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

The Ottawa Hospital Cancer Centre, Ottawa, Ontario

Key details

Phase

Safety & dosing

Sponsor

Ottawa Hospital Research Institute

Collaborators

Knight Therapeutics (USA) Inc

Enrollment target

~54 participants

Started

November 2023

Primary completion

June 2027

Age range

18 Years and older

Sex

Male only

Last updated January 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov